Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Molecular Analysis for Precision Oncology Congress 2022

Start date
14 Oct 2022
End date
16 Oct 2022
Amsterdam, Netherlands

The Molecular Analysis for Precision Oncology Congress 2022 will take place in Amsterdam, Netherlands, from 14 to 16 October. 

MAP is the leading global meeting dedicated to precision oncology, defined as molecular profiling of tumours to identify targetable alterations. This oncology field is fast evolving and has now entered the mainstream of clinical practice.

At MAP 2022, international key opinion leaders will explain how to use genomic data for treating cancer patients, matching such data to a specific drug or therapy, based on the genetic drivers detected in the patients’ tumours, and they will debate about the future challenges in precision oncology.

The MAP Congress is the result of a solid partnership among Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO) and Unicancer, all committed to offering the best care to people with cancer worldwide, through oncology education and research.

We look forward to seeing you at MAP 2022 in Amsterdam!


The Congress will take place at the Amsterdam Conference Centre Beurs van Berlage, Damrak 243, Amsterdam


MAP Congress Team
c/o ESMO Head Office
Via Ginevra 4
6900 Lugano

MAP Organising Partners

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings